NLM Digital Collections

Poly ADP-ribose polymerase (PARP) inhibitors for ovarian cancer: effectiveness and value : final evidence report

Collection:
Health Policy and Services Research
Contributor(s):
Institute for Clinical and Economic Review, issuing body.
Midwest Comparative Effectiveness Public Advisory Council, issuing body.
Publication:
[Boston, Massachusetts] : Institute for Clinical and Economic Review, September 28, 2017
Language(s):
English
Format:
Text
Subject(s):
Ovarian Neoplasms -- drug therapy
Poly(ADP-ribose) Polymerase Inhibitors -- therapeutic use
Comparative Effectiveness Research
Poly(ADP-ribose) Polymerase Inhibitors -- adverse effects
Poly(ADP-ribose) Polymerase Inhibitors -- economics
Treatment Outcome
Humans
United States
Genre(s):
Technical Report
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (vi, ES31, 166 pages))
Illustrations:
Illustrations
NLM Unique ID:
101723925 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101723925